In a 2022 analysis of the role of cathepsin L in neuroblastoma chemoresistance, human tissue samples from the R2 Genomics and Visualisation Platform revealed that higher mRNA levels of cathepsin L were associated with significantly poorer survival and advanced tumour stages, though this finding did not reach statistical significance [17]. Here, CTSL is linked to neuroblastoma.